Stemmelin, Jeanne
Sanofi (France)
4 papers on CoChat
Most cited papers
- Verified
Evidence that the lateral septum is involved in the antidepressant-like effects of the vasopressin V1b receptor antagonist, SSR149415
Stemmelin, J., Lukovic, L., Salome, N., & Griebel, G. (2005) · Neuropsychopharmacology
Neurotransmitter Receptor Influence on BehaviorNeuropeptides and Animal Physiology
Cited by 112
- Verified
The selective GSK3 inhibitor, SAR502250, displays neuroprotective activity and attenuates behavioral impairments in models of neuropsychiatric symptoms of Alzheimer's disease in rodents
Griebel, G., Stemmelin, J., Lopez-Grancha, M., Boulay, D., Boquet, G., Slowinski, F., Pichat, P., Beeské, S., Tanaka, S., Mori, A., et al. (2019) · Scientific Reports
Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research
Cited by 97
- Verified
Differential roles of amygdaloid nuclei in the anxiolytic- and antidepressant-like effects of the V1b receptor antagonist, SSR149415, in rats
Salomé, N., Stemmelin, J., Cohen, C., & Griebel, G. (2006) · Psychopharmacology
Neuropeptides and Animal PhysiologyNeurotransmitter Receptor Influence on Behavior
Cited by 89
- Verified
The vasopressin V1b receptor as a therapeutic target in stress-related disorders
Griebel, G., Simiand, J., Stemmelin, J., Gal, C., & Steinberg, R. (2003) · Current Drug Target -CNS & Neurological Disorders
Neuropeptides and Animal PhysiologyStress Responses and Cortisol
Cited by 74
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free